Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Cerevel Therapeutics Holdings (CERE)
NASDAQ:CERE
RESEARCH TOOLSreports
Cerevel Therapeutics Holdings (CERE) Ownership - Who Owns Cerevel Therapeutics Holdings?
207 Followers
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
| Feb 08, 2024 | John Renger Cso | Sold | $89768 |
| Dec 28, 2023 | Kathleen Tregoning Chief Corporate Affairs Officer | Bought | $31658 |
| Dec 27, 2023 | Kenneth Dipietro Chro | Sold | $331600 |
| Dec 21, 2023 | Kathleen Tregoning Chief Corporate Affairs Officer | Sold | $260449 |
Recent Hedge Fund Trading Activity
Date | Firm | Activity | Value |
|---|---|---|---|
| Dec 31, 2023 | Bought | $398305 | |
| Dec 31, 2023 | Bought | $424000 | |
| Dec 31, 2023 | Bought | $616708 | |
| Dec 31, 2023 | Bought | $2640756 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 10,965,193 | Institution | 6.04% | 460,428,454 | |
| 7,120,430 | Institution | 3.92% | 298,986,856 | |
| 6,478,852 | Institution | 3.57% | 272,046,995 | |
| 2,537,214 | Institution | 1.40% | 106,537,616 | |
| 1,941,302 | Institution | 1.07% | 81,515,271 | |
| 1,903,967 | Institution | 1.05% | 79,947,574 | |
| 1,903,567 | Institution | 1.05% | 79,930,778 | |
| 1,887,585 | Institution | 1.04% | 79,259,694 | |
| 1,835,635 | Institution | 1.01% | 77,078,314 | |
| 1,652,786 | Institution | 0.91% | 69,400,484 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 6,478,852 | Institution | 3.57% | 272,046,995 | |
| 1,941,302 | Institution | 1.07% | 81,515,271 | |
| 1,903,967 | Institution | 1.05% | 79,947,574 | |
| 1,887,585 | Institution | 1.04% | 79,259,694 | |
| 1,835,635 | Institution | 1.01% | 77,078,314 | |
| 1,652,786 | Institution | 0.91% | 69,400,484 | |
| 1,352,758 | Institution | 0.75% | 56,802,308 | |
| 1,204,539 | Institution | 0.66% | 50,578,593 | |
| 1,077,172 | Institution | 0.59% | 45,230,463 | |
| 863,686 | Institution | 0.48% | 36,266,175 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 2,298,272 | Institution | 1.27% | 97,147,957 | |
| 1,851,201 | Institution | 1.02% | 78,250,266 | |
| 1,820,064 | Institution | 1.00% | 76,424,487 | |
| 1,692,334 | Institution | 0.93% | 71,061,105 | |
| 1,325,701 | Institution | 0.73% | 56,037,381 | |
| 1,047,961 | Institution | 0.58% | 44,297,311 | |
| 608,414 | Institution | 0.34% | 25,547,304 | |
| 419,202 | Institution | 0.23% | 17,602,292 | |
| 267,383 | Institution | 0.15% | 11,302,279 | |
| 246,967 | Institution | 0.14% | 10,439,295 |
FAQ
Who Owns Cerevel Therapeutics Holdings (CERE)?
Currently, no data Available
What percentage of Cerevel Therapeutics Holdings (CERE) stock is held by institutional investors?
Currently, no data Available
What percentage of Cerevel Therapeutics Holdings (CERE) stock is held by retail investors?
Currently, no data Available
Who owns the most shares of Cerevel Therapeutics Holdings (CERE)?
Joseph Edelman owns the most shares of Cerevel Therapeutics Holdings (CERE).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.